Cargando…
Effect of levocarnitine administration in patients with chronic liver disease
L-carnitine administration was reported to improve sarcopenia in patients with cirrhosis. However, the amount of evidence from previous studies is not sufficient. The present study aimed to clarify the effect of levocarnitine (L-carnitine) administration on body composition in patients with chronic...
Autores principales: | Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Suzuki, Mitsuyuki, Noguchi, Hirohito, Hirosawa, Hiroshi, Koyama, Fujiko, Kobayashi, Miki, Hirosawa, Shiori, Sugiyama, Kaede, Mitobe, Yuta, Yoshida, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507016/ https://www.ncbi.nlm.nih.gov/pubmed/32973943 http://dx.doi.org/10.3892/etm.2020.9222 |
Ejemplares similares
-
Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease
por: Ohashi, Kazuki, et al.
Publicado: (2021) -
Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease
por: Ohashi, Kazuki, et al.
Publicado: (2019) -
Relationship Between Sarcopenia and Both Physical Activity and Lifestyle in Patients With Chronic Liver Disease
por: Ohashi, Kazuki, et al.
Publicado: (2018) -
Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis
por: Hiramatsu, Akira, et al.
Publicado: (2019) -
Significance of Levocarnitine Treatment in Dialysis Patients
por: Takashima, Hiroyuki, et al.
Publicado: (2021)